Anthony Kram

Anthony Kram serves as a Contracting Specialist responsible for managing the full lifecycle of procurement actions within a specialized federal acquisition environment. He ensures compliance with federal acquisition regulations while executing competitive and transparent contracting processes for high-integrity pharmaceutical products. His role is central to securing mission-critical drug formulations and sterile preparations, aligning procurement strategy with public health objectives. Kram typically handles complex, technical solicitations requiring rigorous scientific and regulatory evaluation, often involving cGMP-compliant manufacturing and supply chain assurance. Kram maintains professional relationships with a broad network of pharmaceutical manufacturers and contract development and manufacturing organizations (CDMOs) that meet stringent FDA and DEA regulatory standards. His contracting approach emphasizes vendor qualification through technical evaluations, quality assurance documentation, and past performance reviews. While no single contractor dominates his portfolio, he consistently engages with firms possessing validated manufacturing capabilities, robust quality control systems, and established supply chain resilience. His working relationships are characterized by collaboration, regulatory alignment, and a focus on long-term reliability over transactional transactions. Kram’s contracting patterns reflect a strong preference for full and open competition, with 100% of his acquisitions issued without set-aside designations. This reflects a strategic decision to prioritize technical capability, regulatory compliance, and manufacturing scale over socioeconomic categorizations, ensuring the most qualified and capable suppliers are selected based on merit. While he does not routinely utilize 8(a), HUBZone, or SDVOSB set-asides, his process remains fully compliant with all socioeconomic contracting statutes and emphasizes fair and open competition as the primary vehicle for achieving mission outcomes. His primary procurement focus is on NAICS 325412 — Pharmaceutical Preparation Manufacturing — encompassing sterile injectables, oral solid dosage forms, and other regulated drug products. Kram specializes in acquiring complex pharmaceuticals requiring validated manufacturing processes, cold chain logistics, and batch traceability. His technical expertise lies in evaluating cGMP compliance, analytical method validation, and biopharmaceutical formulation standards, making him a key steward of the nation’s pharmaceutical supply chain integrity.